Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Hikma Pharmaceuticals (Germany) | Researchclopedia

Back to institutions

Hikma Pharmaceuticals (Germany)

Planeggcompany

41

Works

2,479

Citations

24

h-index

Top Research Topics

Angiogenesis and VEGF in Cancer Cancer, Hypoxia, and Metabolism Adenosine and Purinergic Signaling

Top Researchers

Henrik Daub John Deere (Germany)

110 works9,194 citationsh-index: 37

Recent Research

SECN-15: A novel treatment option for patients with checkpoint inhibitor–resistant tumors by targeting Neuropilin-1 with antisense oligonucleotides.

André Maaske,Anne Sadewasser,et al.

20250 citations

RNA and protein synthesis mechanisms

Immune Cell Function and Interaction

RNA Interference and Gene Delivery

Cancer Research and Treatments

Advanced biosensing and bioanalysis techniques

Endoplasmic Reticulum Stress and Disease

Respiratory viral infections research

Peptidase Inhibition and Analysis

Cancer Mechanisms and Therapy

Sven Michel Hikma Pharmaceuticals (Germany)

106 works3,575 citationsh-index: 27

Eike Staub Merck (Germany)

142 works2,243 citationsh-index: 23

Richard Klar Hikma Pharmaceuticals (Germany)

73 works1,336 citationsh-index: 14

Frank Jaschinski Hikma Pharmaceuticals (Germany)

66 works948 citationsh-index: 14

Markus Helfer Helmholtz Zentrum München

22 works565 citationsh-index: 13

Abstract 7294: Neuropilin-1 specific antisense oligonucleotides exhibit anti-tumor activity in vivo and significantly increase the efficacy of checkpoint inhibitors

André Maaske,Sven Michel,et al.

20250 citations

P-01.13 SECN-15: An antisense oligonucleotide-based approach to target expression of Neuropilin-1 induces anti-tumor activity in vivo and boosts efficacy of checkpoint inhibitors Knockdown of Neuropilin-1 via antisense oligonucleotides induces anti-tumor activity in vivo and furthermore improves the efficacy of checkpoint inhibitors

André Maaske,Sven Michel,et al.

20250 citations

738 Downregulation of neuropilin-1 expression with antisense oligonucleotides in combination with checkpoint inhibitors demonstrates remarkable anti-tumor activity in vivo

André Maaske,Sven Michel,et al.

20240 citations

Characterization of the TLR9-Activating Potential of LNA-Modified Antisense Oligonucleotides

Irene Riera-Tur,Julia Hinterdobler,et al.

20244 citations

Strong single-agent and PD-1/PD-L1 combination antitumor activity of antisense oligonucleotides suppressing Neuropilin 1 expression.

Konstantin Petropoulos,André Maaske,et al.

20240 citations